U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2011
587
Substance Class Protein
Created
by admin
on Mon Mar 31 20:36:20 GMT 2025
Edited
by admin
on Mon Mar 31 20:36:20 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
F7R0FBC1XD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FACTOR XIII CONCENTRATE (HUMAN)
Common Name English
CORIFACT
Preferred Name English
FIBROGAMMIN P
Common Name English
FACTOR XIII (HUMAN)
Common Name English
FACTOR XIII
Common Name English
FACTOR XIII [MI]
Common Name English
FACTOR XIII CONCENTRATE (HUMAN, PLASMA DERIVED)
Common Name English
PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE
Common Name English
HUMAN FACTOR XIII
Common Name English
FIBRINOLIGASE
Common Name English
FIBRIN STABILIZING FACTOR
Common Name English
EC 2.3.2.13
Code English
FACTOR XIII,HUMAN [VANDF]
Common Name English
Factor xiii (fibrin stabilising factor) [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 4484
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
NDF-RT N0000184169
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
WHO-VATC QB02BD07
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
WHO-ATC B02BD07
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
Code System Code Type Description
NDF-RT
N0000175979
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY Increased Coagulation Activity [PE]
SMS_ID
100000124487
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
EVMPD
SUB13818MIG
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
NDF-RT
N0000168159
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY Transglutaminases [Chemical/Ingredient]
RXCUI
1091605
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
MESH
D005176
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
NCI_THESAURUS
C200601
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
DAILYMED
F7R0FBC1XD
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
CAS
9013-56-3
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
RXCUI
4271
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
ALTERNATIVE RxNorm
MERCK INDEX
m5237
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
FDA UNII
F7R0FBC1XD
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
NDF-RT
N0000007914
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY Blood Coagulation Factors [Chemical/Ingredient]
NDF-RT
N0000184155
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY Increased Fibrin Polymerization Activity [PE]
DRUG BANK
DB12909
Created by admin on Mon Mar 31 20:36:20 GMT 2025 , Edited by admin on Mon Mar 31 20:36:20 GMT 2025
PRIMARY
From To
3_5 3_56
3_39 3_67
3_71 3_115
3_98 3_126
3_133 3_177
3_160 3_188
3_193 3_235
3_221 3_247
3_254 3_296
3_282 3_307
3_316 3_358
3_344 3_369
3_376 3_419
3_405 3_430
3_434 3_485
3_466 3_495
3_504 3_547
3_533 3_558
3_562 3_616
3_596 3_626
4_5 4_56
4_39 4_67
4_71 4_115
4_98 4_126
4_133 4_177
4_160 4_188
4_193 4_235
4_221 4_247
4_254 4_296
4_282 4_307
4_316 4_358
4_344 4_369
4_376 4_419
4_405 4_430
4_434 4_485
4_466 4_495
4_504 4_547
4_533 4_558
4_562 4_616
4_596 4_626
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_613
N 2_613
N 3_142
N 3_525
N 4_142
N 4_525
Related Record Type Details
FACTOR XIII CONCENTRATE (HUMAN)
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-ACETYLSERINE W98518XGZ3
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:CENTRIFUGATION CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966